Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]
Phase 1 and Phase 2 results are reported for allogeneic cytokine-induced killer (CIK) cell immunotherapy given to patients who relapsed afte…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma [Phase 3]
Phase 3 trial of combination chemotherapy followed by radiation therapy in children with newly diagnosed Hodgkin lymphoma; results posted af…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Allogeneic Transplantation From Related Haploidentical Donors [Phase 2]
A Phase 2 clinical trial evaluating allogeneic transplantation from related haploidentical donors for blood cancers and leukemia has complet…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating bendamustine hydrochloride for relapsed and primary refractory Hodgkin lymphoma has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of LBH589 (panobinostat) in patients with recurrent or refractory Hodgkin lymphoma or non-Hodgkin lymphoma has been terminated…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Low Dose Chest Computed Tomography (CT) Screening
This update reports a completed clinical trial evaluating low-dose chest CT screening in patients with Hodgkin lymphoma.
-
CLINICAL_TRIALS withdrawal · 2016-12-15Clinical Trial Update: Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment [Phase 2]
Phase 2 trial of rituximab, gemcitabine, and vinorelbine for Hodgkin lymphoma that relapsed or did not respond to prior therapy has been wit…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma [Phase 1]
An early-phase (Phase I/II) study of Abraxane in recurrent and refractory lymphoma was terminated. The trial involved non-Hodgkin lymphoma a…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 1]
Phase 1 trial update of immunostimulatory CpG SD-101 plus radiation therapy for recurrent/progressive lymphoma after allogeneic hematopoieti…
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma [Phase 2]
Phase 2 trial of BEAM chemotherapy regimen followed by autologous stem cell transplantation for lymphoma is completed; results were posted i…
-
CLINICAL_TRIALS withdrawal · 2016-11-08Clinical Trial Update: Prospective Study of Lymphoproliferative Diseases
This clinical trial update notes that the prospective study of lymphoproliferative diseases sponsored by West Virginia University has been w…
-
CLINICAL_TRIALS withdrawal · 2016-11-01Clinical Trial Update: Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant [Phase 2]
A Phase II trial evaluating an EBV-derived dendritic cell vaccine in autologous stem cell transplantation for Hodgkin lymphoma and non-Hodgk…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma [Phase 1, Phase 2]
This clinical trial update summarizes Phase 1/2 results for intravenous AMD3100 (plerixafor) used to collect autologous peripheral blood ste…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluating the impact of a nutritional program during autologous stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine in combination with rituximab, vincristine, and cyclophosphamide for refractory lymphoma completed.
-
CLINICAL_TRIALS other · 2016-10-14Clinical Trial Update: Personalised Program for Women Treated for Hodgkin Disease [NA]
This clinical trial update notes termination of a personalized program study for women treated for Hodgkin lymphoma, including participants …
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating chemotherapy with low-dose radiation for pediatric Hodgkin lymphoma has completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial update for SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma [Phase 3]
This Phase 3 trial update reports the termination of a study comparing three regimens in previously untreated Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-09-12Clinical Trial Update: Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit [Phase 1]
This update reports the completion of a Phase 1 trial evaluating a single treatment with FT1050, an ex-vivo modulated umbilical cord blood u…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Umbilical Cord Blood Transplant for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating umbilical cord blood transplantation for hematologic malignancies has completed enrollment and reporting.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or Refractory
This clinical trial update reports termination of a study evaluating PET-based and donor-based consolidation after salvage therapy in patien…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease [Phase 2]
Phase 2 clinical trial update evaluating treatment in young patients with newly diagnosed, low-stage lymphocyte-predominant Hodgkin disease.…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
An early-phase study of flavopiridol (alvocidib) in patients with relapsed or refractory lymphoma or multiple myeloma; the Phase 1/2 trial w…
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL) [Phase 2]
A Phase 2 multi-centre trial evaluating MBVD in elderly and/or cardiopathic patients with Hodgkin lymphoma has completed.